Liraglutide and tirzepatide are effective for weight loss but have a poorer safety profile and higher discontinuation rates due to adverse events
23 To this end, our group has recently shown how treatment with dulaglutide, over a median observation time of 13 months, exerted an equivalent reduction in HbA1c and body weight in obese and non-obese subjects, the latter being more than a quarter of the entire population treated with the GLP-1RAs in real-world settings
Need to boost testosterone
The drugs have already wiped 780m from household spend in the year to 28 February 2026, according to NIQ statistics released in early June
Ozempic breath can be embarrassing for GLP-1 users but its turned out to be good news for confectioners
Not only is there no data to support the practice of Ozempic microdosing, but there are also serious safety concerns, as outlined above